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ABSTRACT
The synthesis, antibacterial and antifungal activities of a novel
series of 5-substituted isoxazolidine derivatives [3a,b(i–viii)] were
described. The synthesis of title compounds was achieved via a 1,3-
dipolar cycloaddition of C-(4-biphenyl)-N-(4-methylphenyl)nitrone,
C-(4-biphenyl)-N-(4-chlorophenyl) nitrone with monosubstituted
alkenes.
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Nitrones are attractive class of 1,3-dipoles, because of their
versatile synthetic applications in organic synthesis.[1–4] Recently, we
showed that nitrones are convenient class of compounds used for the
synthesis of ultimate carcinogens,[5,6] which are biologically interesting
species. The nitrone addition to unsaturated substrate has been
utilized to develop a synthesis of b-lactams,[7,8] natural products,
versatile synthetic intermediates,[9] and biologically interesting
compounds.[10]
In the interest of the above, we herein reported the synthesis and
characterization of some novel aryl nitrones. The nitrones obtained
were used to synthesize biologically interesting novel isoxazolidines,
which were tested for antibacterial and antifungal activities.
Nitrones were synthesized by the reduction of a mixture of nitro
compounds and 4-biphenyl carboxaldehyde with zinc dust using histidine
as catalyst.[11] The nitrones were found to be light sensitive and hygro-
scopic. Hence they were stored in the dark until further use, the obtained
nitrones were structurally characterized by using 1HNMR, IR, and C, H,
N, analysis.
The novel 5-substituted isoxazolidines were obtained by reﬂuxing the
nitrones 2a and 2b with equimolar amount of monosubstituted alkenes in
toluene/xylene. The cycloaddition of all monosubstituted oleﬁns with
nitrone showed high regioselectivity and gave 5-substituted derivatives
predominantly (Sch. 1).[3]
The major products of 5-substituted isoxazolidine derivatives were
separated on silica gel column using appropriate combination of
chloroform, hexane, benzene, and petroleum ether as eluents. The
reaction condition and the physical data of cycloadducts are given in
Table 1. All synthesized isoxazolidines were structurally characterized
by using IR, 1HNMR, and C, H, N analysis.
The results of antibacterial and antifungal activities of the mole-
cules are summarized in Tables 2 and 3. Introduction of chlorine
substituent into phenyl ring proved to be very beneﬁcial for activity,
thus 3b(i–viii) series showed better Minimum Inhibition Concentration
(MIC) values against all tested fungi and bacteria compared to 3a(i–viii)
series.
Compounds 3a(iv), 3a(vii), 3b(iv), 3b(vi), and 3b(vii) showed better
antifungal activity compared to standard drug Nystatin against
Botrydiplodia theobromae.
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EXPERIMENTAL SECTION
Melting points were determined on SELACO-650 hot stage
apparatus and are uncorrected. IR (nujol) spectra were measured on
Shimadzu 8300 IR spectrophotometer, 1HNMR were recorded on
Shimadzu AMX 400-Bruker, 400MHz spectrometer by using CDCl3 as
solvent and TMS as an internal standard (chemical shift in  ppm).
Elemental analyses were obtained on a Vario-EL instrument. Column
and TLC were done with silica gel BDH 60–120 mesh and pre-coated
silica gel plates.
Procedure for the Synthesis of C-(4-Biphenyl)-
N-(4-methylphenyl) and C-(4-Biphenyl)-
N-(4-chlorophenyl) Nitrones, 2a and 2b
Nitrones were synthesized according to the procedure we reported
earlier.[11]
Synthesis of C-(4-biphenyl)-N-(4-methylphenyl) nitrone, 2a: This was
obtained from 4-methyl nitrobenzene and 4-biphenyl carboxaldehyde as
a white crystalline solid; yield 813mg (91%), m.p. 225C. 1HNMR
(Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 2.42 (s, 3H, Ar-CH3);
7.25–7.29 (d, 2H, Ar-H); 7.38–7.51 (m, 3H, Ar-H); 7.64–7.74 (m, 6H,
Ar-H); 7.95 (s, 1H, CH¼N); 8.45–8.50 (d, 2H, Ar-H). Anal. calcd.
Scheme 1.
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C20H17NO: C, 83.62; H, 5.92; N, 4.88. Found: C, 83.32; H, 5.48; N, 4.94.
IR (Nujol):  (cm1): 1548 (C¼N); 1140 (NO).
Synthesis of C-(4-biphenyl)-N-(4-chlorophenyl) nitrone, 2b: This was
obtained from 4-chloronitrobenzene and 4-biphenyl carboxaldehyde as a
white crystalline solid; yield: 812mg (96%), m.p. 307C. 1HNMR
(Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 7.44–7.49 (m, 5H,
Ar-H); 7.65–7.79 (m, 6H, Ar-H); 7.94 (s, 1H, CH¼N); 8.44–8.48 (d, 2H,
Ar-H). Anal. calcd. C19H14NOCl: C, 74.27; H, 4.56; N, 4.56. Found: C,
74.14; H, 4.72; N, 4.68. IR (Nujol):  (cm1): 1572 (C¼N); 1152 (NO).
Table 3. The minimum antibacterial and antifungal inhibitory concentrations
(mgm/mL) of isoxazolidines 3b(i–viii).
Isoxazolidines
Tested bacteria Tested fungus
E. coli B. cereus S. aureus A. ﬂavus F. moniliforme B. theobromae
Ampicillin 5.0 3.0 2.5 Nystatin 12.0 14.0 21.0
3b(i) 60.0 100 120 30.0 40.0 40.0
3b(ii) 50.0 120 100 20.0 30.0 30.0
3b(iii) 60.0 100 70.0 30.0 40.0 40.0
3b(iv) 70.0 50.0 50.0 40.0 30.0 20.0
3b(v) 70.0 110 80.0 20.0 40.0 40.0
3b(vi) 50.0 70.0 70.0 50.0 50.0 20.0
3b(vii) 60.0 60.0 50.0 40.0 30.0 20.0
3b(viii) 70.0 50.0 50.0 20.0 20.0 30.0
Table 2. The minimum antibacterial and antifungal inhibitory concentrations
(mgm/mL) of isoxazolidines 3a(i–viii).
Isoxazolidines
Tested bacteria Tested fungus
E. coli B. cereus S. aureus A. ﬂavus F. moniliforme B. theobromae
Ampicillin 5.0 3.0 2.5 Nystatin 12.0 14.0 21.0
3a(i) 70.0 70.0 100 40.0 60.0 60.0
3a(ii) 50.0 110 70.0 20.0 50.0 50.0
3a(iii) 70.0 100 60.0 30.0 20.0 40.0
3a(iv) 50.0 70.0 50.0 40.0 40.0 20.0
3a (v) 60.0 100 70.0 30.0 40.0 40.0
3a(vi) 70.0 50.0 70.0 40.0 60.0 40.0
3a(vii) 50.0 60.0 50.0 20.0 40.0 20.0
3a(viii) 70.0 50.0 50.0 40.0 20.0 40.0
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General Procedure for the Synthesis of
Novel Isoxazolidines, [3a,b (i–viii)]
Equimolar mixture of nitrones 2a and 2b and diﬀerent alkenes were
dissolved in 10mL of toluene/xylene. The reaction mixture was reﬂuxed
till the reaction completes which was monitored by TLC. The pure
products were separated by using silica gel column.
Synthesis of 2-(4-methylphenyl)-3-(4-biphenyl)-5-cyano isoxazolidines,
3a(i): It was obtained from equimolar mixture of C-(4-biphenyl)-N-(4-
methylphenyl) nitrone 2a (500mg) and acrylonitrile (0.31mL). 1HNMR
(Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 2.28 (s, 3H, Ar-CH3);
2.66–2.82 (q, 2H, H4); 4.45 (t, 1H, H5); 5.08 (t, 1H, H3); 6.92 (d, 2H,
Ar-H); 7.42 (d, 2H, Ar-H (BP); 7.52 (t, 1H, Ar-H (BP); 7.56 (d, 2H,
Ar-H); 7.63 (t, 2H, Ar-H (BP); 7.69 (d, 4H, Ar-H (BP). Anal. calcd.
for C23H20N2O: C, 81.18; H, 5.88; N, 8.23. Found: C, 81.08; H, 5.92;
N, 8.08. IR (Nujol):  (cm1): 1748 (CO); 1278 (NO).
Synthesis of 2-(4-methylphenyl)-3-(4-biphenyl)-5-phenyl isoxazoli-
dines, 3a(ii): It was obtained from equimolar mixture of C-(4-biphenyl-
N-(4-methylphenyl) nitrone 2a (500mg) and styrene (0.25mL). 1HNMR
(Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 2.28 (s, 3H, Ar-CH3);
2.69–2.85 (q, 2H, H4); 5.03 (t, 1H, H5); 5.12 (t, 1H, H3); 6.92 (d, 2H,
Ar-H); 7.29–7.41 (m, 5H,Ar-H); 7.42 (d, 2H,Ar-H (BP)); 7.52 (t, 1H,Ar-H
(BP); 7.55 (d, 2H, Ar-H); 7.64 (t, 2H, Ar-H (BP)); 7.69 (d, 4H, Ar-H
(BP)). Anal. calcd. for C28H25NO: C, 85.93; H, 6.39; N, 3.58. Found: C,
85.68; H, 6.26; N, 3.72. IR (Nujol):  (cm1): 1712 (CO); 1246 (NO).
Synthesis of 2-(4-methylphenyl)-3-(4-biphenyl)-5-benzoate isoxazoli-
dines, 3a(iii): It was obtained from equimolar mixture of C-(4-biphe-
nyl)-N-(4-methylphenyl) nitrone 2a (500mg) and vinyl benzoate
(0.26mL). 1HNMR (Bruker-AMX-400, 400MHz, CDCl3);  (ppm):
2.29 (s, 3H, Ar-CH3); 2.65–2.84 (q, 2H, H4); 4.72 (t, 1H, H5); 5.12 (t,
1H, H3); 6.93 (d, 2H, Ar-H); 7.28–7.50 (m, 3H, Ar-H); 7.42 (d, 2H, Ar-H,
BP); 7.52 (t, 1H, Ar-H, BP); 7.55 (d, 2H, Ar-H); 7.64 (t, 2H, Ar-H, BP);
7.79 (d, 4H, Ar-H, BP). 7.81 (d, 2H, Ar-H). Anal. calcd. for C29H25NO3:
C, 80; H, 5.75; N, 3.22. Found: C, 80.08; H, 5.62; N, 3.14. IR (Nujol):
 (cm1): 1752 (C¼O); 1732 (CO); 1270 (NO).
Synthesis of 2-(4-methylphenyl)-3-(4-biphenyl)-5-ethylate isoxazoli-
dines, 3a(iv): It was obtained from equimolar mixture of C-(4-biphe-
nyl)-N-(4-methylphenyl) nitrone 2a (500mg) and ethyl acrylate
(0.17mL). 1HNMR (Bruker-AMX-400, 400MHz, CDCl3);  (ppm):
0.93 (t, 3H, CH3); 2.28 (s, 3H, Ar-CH3); 2.66–2.84 (q, 2H, H4); 3.62
(q, 2H, CH2); 4.46 (t, 1H, H5); 5.12 (t, 1H, H3); 6.92 (d, 2H, Ar-H);
7.42 (d, 2H, Ar-H, BP); 7.52 (t, 1H, Ar-H, BP); 7.55 (d, 2H, Ar-H);
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7.64 (t, 2H, Ar-H, BP); 7.79 (d, 4H, Ar-H, BP). Anal. calcd. for
C25H25NO3: C, 77.52; H, 6.46; N, 3.62. Found: C, 77.46; H, 6.36; N,
3.44. IR (Nujol):  (cm1): 1726 (C¼O); 1708 (CO); 1240 (NO).
Synthesis of 2-(4-methylphenyl)-3-(4-biphenyl)-5-methylene acetate
isoxazolidine, 3a(v): It was obtained from equimolar mixture of
C-(4-biphenyl)-N-(4-methylphenyl) nitrone 2a (500mg) and allyl acetate
(0.23mL). 1HNMR (Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 2.28
(s, 3H, Ar-CH3); 2.42 (d, 2H, CH2); 2.64–2.82 (q, 2H, H4); 3.42 (s, 3H,
OCH3); 4.25 (t, 1H, H5); 5.12 (t, 1H, H3); 6.92 (d, 2H, Ar-H); 7.42
(d, 2H, Ar-H, BP); 7.52 (t, 1H, Ar-H, BP); 7.53 (d, 2H, Ar-H); 7.64 (t,
2H, Ar-H, BP); 7.79 (d, 4H, Ar-H, BP). Anal. calcd. for C25H25NO3: C,
77.72; H, 6.22; N, 3.62. Found: C, 77.58; H, 6.16; N, 3.58. IR (Nujol): 
(cm1): 1720 (CO); 1250 (NO).
Synthesis of 2-(4-methylphenyl)-3-(4-biphenyl)-5-methylene hydroxy
isoxazolidines, 3a(vi): It was obtained from equimolar mixture of C-(4-
biphenyl)-N-(4-methylphenyl) nitrone 2a (500mg) and allyl alcohol
(0.24mL). 1HNMR (Bruker-AMX-400, 400MHz, CDCl3);  (ppm):
2.28 (s, 3H, Ar-CH3); 2.66–2.85 (q, 2H, H4); 3.64 (d, 2H, CH2); 4.76
(t, 1H, H5); 5.15 (t, 1H, H3); 5.25 (s, 1H, OH); 6.92 (d, 2H, Ar-H);
7.42 (d, 2H, Ar-H, BP); 7.52 (t, 1H, Ar-H, BP); 7.55 (d, 2H, Ar-H);
7.63 (t, 2H, Ar-H, BP); 7.79 (d, 4H, Ar-H, BP). Anal. calcd. for
C23H23NO2: C, 80; H, 6.66; N, 4.06. Found: C, 80.04; H, 6.52; N, 4.12.
IR (Nujol):  (cm1): 1728 (CO); 1262 (NO).
Synthesis of 2-(4-methylphenyl)-3-(4-biphenyl)-5-(3-cyclohexene)
isoxazolidines, 3a(vii): It was obtained from equimolar mixture of C-(4-
biphenyl)-N-(4-methylphenyl) nitrone 2a (500mg) and 4-vinyl-1-cyclo-
hexene (0.21mL). 1HNMR (Bruker-AMX-400, 400MHz, CDCl3);
 (ppm): 1.38–1.42 (m, 2H, CH2, cyclohexene); 1.52 (s, 1H, cyclohexene);
2.26 (s, 3H, Ar-H); 2.28–2.31 (m, 2H, cyclohexene); 2.33–2.38 (m, 2H,
cyclohexene); 2.65–2.83 (q, 2H, H4); 4.82 (m, 1H, CH); 5.12 (t, 1H, CH);
5.6–5.66 (m, 2H, cyclohexene); 6.92 (d, 2H, Ar-H); 7.42 (d, 2H, Ar-H, BP);
7.52 (t, 1H, Ar-H, BP); 7.55 (d, 2H, Ar-H); 7.63 (t, 2H, Ar-H, BP); 7.74
(d, 4H, Ar-H, BP). Anal. calcd. for C28H29NO: C, 85.06; H, 7.34; N,
3.54. Found: C, 85.12; H, 7.18; N, 3.48. IR (Nujol):  (cm1): 1744 (CO);
1270 (NO).
Synthesis of 2-(4-methylphenyl)-3-(4-biphenyl)-5-methylate isoxazoli-
dines, 3a(viii): It was obtained from equimolar mixture of C-(4-biphe-
nyl)-N-(4-methylphenyl) nitrone 2a (500mg) and methyl acrylate
(0.17mL). 1HNMR (Bruker-AMX-400, 400MHz, CDCl3);  (ppm):
2.28 (s, 3H, Ar-CH3); 2.67–2.85 (q, 2H, H4); 3.41 (s, 3H, OCH3); 4.44
(t, 1H, CH); 5.14 (t, 1H, CH); 6.92 (d, 2H, Ar-H); 7.43 (d, 2H, Ar-H, BP);
7.53 (t, 1H, Ar-H, BP); 7.55 (d, 2H, Ar-H); 7.64 (t, 2H, Ar-H, BP); 7.73
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(d, 4H, Ar-H, BP). Anal. calcd. for C24H23NO3: C, 77.2; H, 6.17; N, 3.75.
Found: C, 77.12; H, 6.12; N, 3.58. IR (Nujol):  (cm1): 1726 (C¼O);
1708 (CO); 1240 (NO).
Synthesis of 2-(4-chlorophenyl)-3-(4-biphenyl)-5-cyano isoxazolidines,
3b(i): It was obtained from equimolar mixture of C-(4-biphenyl)-N-(4-
chlorophenyl) nitrone 2b (500mg) and acrylonitrile (0.30mL). 1HNMR
(Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 2.83–3.01 (q, 2H, H4);
4.46 (t, 1H, H5); 5.10 (t, 1H, H3); 7.28 (d, 2H, Ar-H); 7.41 (d, 2H, Ar-H
(BP)); 7.52 (t, 1H, Ar-H (BP)); 7.64 (t, 2H, Ar-H (BP)); 7.77 (d, 2H,
Ar-H); 7.69 (d, 4H, Ar-H (BP)). Anal. calcd. C22H17N2OCl: C, 73.3;
H, 4.72; N, 7.28. Found: C, 73.08; H, 4.88; N, 7.64. IR (Nujol): 
(cm1): 1734 (CO); 1274 (NO).
Synthesis of 2-(4-chlorophenyl)-3-(4-biphenyl)-5-phenyl isoxazolidines,
3b(ii): It was obtained from equimolar mixture of C-(4-biphenyl)-N-(4-
chlorophenyl) nitrone 2b (500mg) and styrene (0.25mL). 1HNMR
(Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 2.88–3.06 (q, 2H, H4);
5.05 (t, 1H, H5); 5.14 (t, 1H, H3); 7.29 (d, 2H, Ar-H); 7.29–7.41 (m, 5H,
Ar-H); 7.42 (d, 2H, Ar-H (BP)); 7.52 (t, 1H, Ar-H (BP)); 7.64 (t, 2H,
Ar-H (BP)); 7.77 (d, 2H, Ar-H); 7.79 (d, 4H, Ar-H (BP)). Anal. calcd.
C27H22NOCl: C, 78.83; H, 5.35; N, 3.41. Found: C, 78.68; H, 5.52; N,
3.28. IR (Nujol):  (cm1): 1700 (CO); 1240 (NO).
Synthesis of 2-(4-chlorophenyl)-3-(4-biphenyl)-5-benzoate isoxazoli-
dines, 3b(iii): It was obtained from equimolar mixture of C-(4-biphenyl)-
N-(4-chlorophenyl) nitrone 2b (500mg) and vinyl benzoate (0.15mL).
1HNMR (Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 2.85–3.03 (q,
2H, H4); 4.72 (t, 1H, H5); 5.15 (t, 1H, H3); 7.28 (d, 2H, Ar-H); 7.29–7.50
(m, 3H, Ar-H); 7.42 (d, 2H, Ar-H, BP); 7.53 (t, 1H, Ar-H, BP); 7.64 (t, 2H,
Ar-H, BP); 7.78 (d, 2H, Ar-H); 7.79 (d, 4H, Ar-H, BP). 7.81 (d, 2H, Ar-H).
Anal. calcd. C28H22NO3Cl: C, 73.85; H, 4.86; N, 3.1. Found: C, 73.58; H,
4.58; N, 3.08. IR (Nujol):  (cm1): 1738 (C¼O); 1730 (CO); 1268 (NO).
Synthesis of 2-(4-chlorophenyl)-3-(4-biphenyl)-5-ethylate isoxazoli-
dines, 3b(iv): It was obtained from equimolar mixture of C-(4-biphenyl)-
N-(4-chlorophenyl) nitrone 2b (500mg) and ethyl acrylate (0.21mL).
1HNMR (Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 0.93 (t, 3H,
CH3); 2.84–3.02 (q, 2H, H4); 3.62 (q, 2H, CH2); 4.44 (t, 1H, H5); 5.13
(t, 1H, H3); 7.28 (d, 2H, Ar-H); 7.41 (d, 2H, Ar-H, BP); 7.52 (t, 1H, Ar-H,
BP); 7.64 (t, 2H, Ar-H, BP); 7.77 (d, 2H, Ar-H); 7.79 (d, 4H, Ar-H, BP).
Anal. calcd. C24H22NO3Cl: C, 70.76; H, 5.41; N, 3.44. Found: C, 70.62; H,
5.36; N, 3.38. IR (Nujol):  (cm1): 1722 (C¼O); 1700 (CO); 1232 (NO).
Synthesis of 2-(4-chlorophenyl)-3-(4-biphenyl)-5-methylene acetate iso-
xazolidines, 3b(v): It was obtained from equimolar mixture of C-(4-biphe-
nyl)-N-(4-chlorophenyl) nitrone 2b (500mg) and allyl acetate (0.1mL).
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1HNMR (Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 2.42 (d, 2H,
CH2); 2.84–3.02 (q, 2H, H4); 3.42 (s, 3H, OCH3); 4.26 (t, 1H, H5); 5.12 (t,
1H, H3); 7.26 (d, 2H, Ar-H); 7.41 (d, 2H, Ar-H, BP); 7.52 (t, 1H, Ar-H,
BP); 7.64 (t, 2H, Ar-H, BP); 7.77 (d, 2H, Ar-H); 7.79 (d, 4H, Ar-H, BP).
Anal. calcd. C24H22NO3Cl: C, 70.76; H, 5.40; N, 3.44. Found: C, 70.58;
H, 5.38; N, 3.38. IR (Nujol):  (cm1): 1740 (CO); 1266 (NO).
Synthesis of 2-(4-chlorophenyl)-3-(4-biphenyl)-5-methylene hydroxy
isoxazolidine, 3b(vi): It was obtained from equimolar mixture of C-(4-
biphenyl)-N-(4-chlorophenyl)nitrone 2b (500mg) and allyl alcohol
(0.15mL). 1HNMR (Bruker-AMX-400, 400MHz, CDCl3;  (ppm):
2.74–2.92 (q, 2H, H4); 3.64 (d, 2H, CH2); 4.76 (t, 1H, H5); 5.12 (t, 1H,
H3); 5.25 (s, 1H, OH); 7.28 (d, 2H, Ar-H); 7.41 (d, 2H, Ar-H, BP); 7.52 (t,
1H, Ar-H, BP); 7.64 (t, 2H, Ar-H, BP); 7.77 (d, 2H, Ar-H); 7.79 (d, 4H,
Ar-H, BP). Anal. calcd. C22H20NO2Cl: C, 72.33; H, 5.48; N, 3.84. Found:
C, 72.18; H, 5.38; N, 3.72. IR (Nujol):  (cm1): 1720 (CO); 1248 (NO).
Synthesis of 2-(4-chlorophenyl)-3-(4-biphenyl)-5-(3-cyclohexene)
isoxazolidines, 3b(vii): It was obtained from equimolar mixture of
C-(4-biphenyl)-N-(4-chlorophenyl) nitrone 2b (500mg) and 4-vinyl-1-
cyclohexene (0.25mL). 1HNMR (Bruker-AMX-400, 400MHz, CDCl3);
 (ppm): 1.38–1.42 (m, 2H, CH2, cyclohexene); 1.52 (s, 1H, cyclohexene);
2.28–2.31 (m, 2H, cyclohexene); 2.33–2.38 (m, 2H, cyclohexene);
2.85–3.03 (q, 2H, H4); 4.82 (m, 1H, CH); 5.14 (t, 1H, H3); 5.6–5.66 (m,
2H, cyclohexene); 7.28 (d, 2H, Ar-H); 7.41 (d, 2H, Ar-H, BP); 7.52 (t, 1H,
Ar-H, BP); 7.63 (t, 2H, Ar-H, BP); 7.77 (d, 2H, Ar-H); 7.79 (d, 4H, Ar-H,
BP). Anal. calcd. C27H26NOCl: C, 78.07; H, 6.26; N, 3.37. Found: C,
78.14; H, 6.18; N, 3.18. IR (Nujol):  (cm1): 1730 (CO); 1260 (NO).
Synthesis of 2-(4-chlorophenyl)-3-(4-biphenyl)-5-methyl isoxazolidines,
3b(viii): It was obtained from equimolar mixture of C-(4-biphenyl)-N-(4-
chlorophenyl) nitrone 2b (500mg) and methyl acrylate (0.35mL).
1HNMR (Bruker-AMX-400, 400MHz, CDCl3);  (ppm): 2.87–3.05 (q,
2H, H4); 3.41 (s, 3H, OCH3); 4.45 (t, 1H, H5); 5.12 (t, 1H, H3); 7.28 (d,
2H, Ar-H); 7.41 (d, 2H, Ar-H, BP); 7.52 (t, 1H, Ar-H, BP); 7.64 (t, 2H,
Ar-H, BP); 7.77 (d, 2H, Ar-H); 7.79 (d, 4H, Ar-H, BP). Anal. calcd.
C23H20NO3Cl: C, 70.23; H, 5.09; N, 3.56. Found: C, 70.14; H, 5.12; N,
3.42. IR (Nujol):  (cm1): 1745 (CO); 1278 (NO).
Microorganisms Used for the Antimicrobial Activity
Bacteria: Escherichia coli, Bacillus cereus, and Staphylococcus aureus.
Fungus: Aspergillus ﬂavus, Fusarium moniliforme and Botrydiplodia
theobromae.
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Determination of Antibacterial Activity
The isoxazolidines were tested for antibacterial activity by serial
tube dilution technique[12,13] at diﬀerent concentrations (10, 20. . . . . .
150 mg/mL) against E. coli (Gram-negative), B. cereus (Gram-positive)
and S. aureus (Gram-positive) microbes. Ampicillin was used as reference
standard and CHCl3 as control. To the culture tubes containing 1.9mL
of media, 0.1mL of test solution was added at sterile conditions.
To all the tubes including standard and controls, the fresh inoculum
was added using Himedia ﬂexiloop 4 calibrated to 0.1mL. After incubat-
ing all the tubes at 37C for 24 h, their absorbance was recorded at
640 nm along with ampicillin. Percentage of inhibition was calculated
as follows,
% Inhibition ¼ 100ðPQÞ
P
where P¼ absorbance without the test sample and Q¼ absorbance with
test sample. Then the minimum inhibitor concentration (MIC) was
recorded in mg/mL.
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